600668 尖峰集团
已收盘 03-24 15:00:00
资讯
新帖
简况
股市必读：尖峰集团（600668）3月23日收盘跌5.51%，主力净流出740.25万元
证券之星 · 02:57
股市必读：尖峰集团（600668）3月23日收盘跌5.51%，主力净流出740.25万元
每周股票复盘：尖峰集团（600668）子公司药品上市申请未获批准
证券之星 · 03-22 02:39
每周股票复盘：尖峰集团（600668）子公司药品上市申请未获批准
尖峰集团(600668.SH)：复方托吡卡胺滴眼液上市申请不予批准
智通财经 · 03-19
尖峰集团(600668.SH)：复方托吡卡胺滴眼液上市申请不予批准
每周股票复盘：尖峰集团（600668）回购进展披露
证券之星 · 03-08
每周股票复盘：尖峰集团（600668）回购进展披露
每周股票复盘：尖峰集团（600668）回购进展支付2091.67万元
证券之星 · 02-08
每周股票复盘：尖峰集团（600668）回购进展支付2091.67万元
尖峰集团（600668）披露以集中竞价交易方式回购公司股份的进展公告，2月2日股价下跌1.8%
证券之星 · 02-02
尖峰集团（600668）披露以集中竞价交易方式回购公司股份的进展公告，2月2日股价下跌1.8%
每周股票复盘：尖峰集团（600668）预计2025年净利4.6亿
证券之星 · 02-01
每周股票复盘：尖峰集团（600668）预计2025年净利4.6亿
尖峰集团（600668）披露2025年年度业绩预告，1月27日股价下跌1.46%
证券之星 · 01-27
尖峰集团（600668）披露2025年年度业绩预告，1月27日股价下跌1.46%
尖峰集团(600668.SH)发预增，预计2025年年度归母净利润同比增加325.97%左右
智通财经 · 01-27
尖峰集团(600668.SH)发预增，预计2025年年度归母净利润同比增加325.97%左右
每周股票复盘：尖峰集团（600668）子公司撤回药品注册申请因需完善资料
证券之星 · 01-18
每周股票复盘：尖峰集团（600668）子公司撤回药品注册申请因需完善资料
尖峰集团最新公告：子公司尖峰药业主动撤回“C2235和C2235片”药品注册临床试验申请
证券之星 · 01-15
尖峰集团最新公告：子公司尖峰药业主动撤回“C2235和C2235片”药品注册临床试验申请
每周股票复盘：尖峰集团（600668）尖峰药业通过GMP检查
证券之星 · 2025-12-28
每周股票复盘：尖峰集团（600668）尖峰药业通过GMP检查
尖峰集团(600668.SH)子公司尖峰药业通过药品GMP符合性检查
智通财经 · 2025-12-23
尖峰集团(600668.SH)子公司尖峰药业通过药品GMP符合性检查
每周股票复盘：尖峰集团（600668）取消监事会并修订多项内控制度
证券之星 · 2025-11-23
每周股票复盘：尖峰集团（600668）取消监事会并修订多项内控制度
尖峰集团（600668）披露取消监事会并修订《公司章程》议案获通过，11月21日股价下跌3.44%
证券之星 · 2025-11-21
尖峰集团（600668）披露取消监事会并修订《公司章程》议案获通过，11月21日股价下跌3.44%
尖峰集团(600668.SH)：JFAN-1001甲磺酸盐胶囊获得药物临床试验批准
智通财经 · 2025-11-14
尖峰集团(600668.SH)：JFAN-1001甲磺酸盐胶囊获得药物临床试验批准
尖峰集团（600668）披露拟取消监事会并调整公司治理结构，11月12日股价下跌0.33%
证券之星 · 2025-11-12
尖峰集团（600668）披露拟取消监事会并调整公司治理结构，11月12日股价下跌0.33%
每周股票复盘：尖峰集团（600668）回购耗资1031.03万元，占比0.211%
证券之星 · 2025-11-09
每周股票复盘：尖峰集团（600668）回购耗资1031.03万元，占比0.211%
尖峰集团（600668）披露以集中竞价交易方式回购公司股份的进展公告，11月03日股价下跌0.25%
证券之星 · 2025-11-03
尖峰集团（600668）披露以集中竞价交易方式回购公司股份的进展公告，11月03日股价下跌0.25%
每周股票复盘：尖峰集团（600668）Q3净利增39.76%
证券之星 · 2025-11-02
每周股票复盘：尖峰集团（600668）Q3净利增39.76%
加载更多
公司概况
公司名称：
浙江尖峰集团股份有限公司
所属行业：
非金属矿物制品业
上市日期：
1993-07-28
主营业务：
浙江尖峰集团股份有限公司的主营业务是以建材和医药为主，以健康品、商贸物流、电缆等业务为辅。公司的主要产品是水泥、药品。
发行价格：
1.00
{"stockData":{"symbol":"600668","market":"SH","secType":"STK","nameCN":"尖峰集团","latestPrice":10.15,"timestamp":1774335600000,"preClose":9.78,"halted":0,"volume":4866645,"delay":0,"changeRate":0.0378,"floatShares":413000000,"shares":413000000,"eps":1.6642,"marketStatus":"已收盘","change":0.37,"latestTime":"03-24 15:00:00","open":9.89,"high":10.2,"low":9.82,"amount":48664800,"amplitude":0.0389,"askPrice":10.15,"askSize":1062,"bidPrice":10.14,"bidSize":422,"shortable":0,"etf":0,"ttmEps":1.6642,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774402200000},"marketStatusCode":5,"adr":0,"adjPreClose":9.78,"symbolType":"stock","openAndCloseTimeList":[[1774315800000,1774323000000],[1774328400000,1774335600000]],"highLimit":10.76,"lowLimit":8.8,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":412900594,"isCdr":false,"pbRate":0.73,"roa":"--","peRate":6.099027,"roe":"11.85%","epsLYR":0.31,"committee":-0.419718,"marketValue":4191000000,"turnoverRate":0.0118,"status":0,"floatMarketCap":4191000000},"requestUrl":"/m/hq/s/600668","defaultTab":"news","newsList":[{"id":"2621086755","title":"股市必读：尖峰集团（600668）3月23日收盘跌5.51%，主力净流出740.25万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621086755","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621086755?lang=zh_cn&edition=full","pubTime":"2026-03-24 02:57","pubTimestamp":1774292228,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，尖峰集团报收于9.78元，下跌5.51%，换手率1.58%，成交量6.51万手，成交额6483.2万元。来自资金流向：主力资金当日净流出740.25万元，占总成交额11.42%。交易信息汇总股价提醒3月23日尖峰集团收盘报9.78元，跌5.51%，当日成交651.36万元。根据收盘数据统计，该股已连续4日下跌。前10个交易日资金流向情况：主力资金累计净流出9250.58万元，股价累计下跌11.19%；融资余额累计减少668.16万元，融券余量累计增加400股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400002638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0186","600668","BK0235"],"gpt_icon":0},{"id":"2621799341","title":"每周股票复盘：尖峰集团（600668）子公司药品上市申请未获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2621799341","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621799341?lang=zh_cn&edition=full","pubTime":"2026-03-22 02:39","pubTimestamp":1774118350,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，尖峰集团报收于10.35元，较上周的11.04元下跌6.25%。本周关注点公司公告汇总：子公司尖峰药业收到复方托吡卡胺滴眼液单剂量规格药品上市申请不予批准通知。公司公告汇总尖峰集团全资子公司浙江尖峰药业有限公司收到国家药品监督管理局签发的复方托吡卡胺滴眼液《药品上市申请不予批准通知书》，审批结论为不批准，原因为提供的研究资料不能证明该规格的合理性。尖峰药业同时申报的多剂量规格产品目前仍在审评中。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0186","BK0235","600668"],"gpt_icon":0},{"id":"2620621786","title":"尖峰集团(600668.SH)：复方托吡卡胺滴眼液上市申请不予批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2620621786","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620621786?lang=zh_cn&edition=full","pubTime":"2026-03-19 15:45","pubTimestamp":1773906339,"startTime":"0","endTime":"0","summary":"智通财经APP讯，尖峰集团(600668.SH)公告全资子公司浙江尖峰药业有限公司(简称“尖峰药业”)收到国家药品监督管理局核准签发的复方托吡卡胺滴眼液(0.5ml：托吡卡胺2.5mg与盐酸去氧肾上腺素2.5mg)《药品上市申请不予批准通知书》。理由如下：提供的研究资料不能证明本品规格的合理性，不符合《关于印发化学药品技术标准等5个药品审评技术标准的通知》(国食药监注[2008]271号)的要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415887.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"尖峰集团(600668.SH)：复方托吡卡胺滴眼液上市申请不予批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0235","600668","BK0186","BK0188"],"gpt_icon":0},{"id":"2617663382","title":"每周股票复盘：尖峰集团（600668）回购进展披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2617663382","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617663382?lang=zh_cn&edition=full","pubTime":"2026-03-08 02:52","pubTimestamp":1772909530,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，尖峰集团报收于11.12元，较上周的11.47元下跌3.05%。本周，尖峰集团3月2日盘中最高价报11.36元。本周关注点公司公告汇总：尖峰集团已累计回购1,789,200股，占公司总股本的0.433%，支付资金总额2,091.67万元。上述回购进展符合相关规定及方案要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800000952.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0188","600668","BK0235"],"gpt_icon":0},{"id":"2609526240","title":"每周股票复盘：尖峰集团（600668）回购进展支付2091.67万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609526240","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609526240?lang=zh_cn&edition=full","pubTime":"2026-02-08 03:19","pubTimestamp":1770491950,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，尖峰集团报收于11.03元，较上周的11.09元下跌0.54%。本周，尖峰集团2月5日盘中最高价报11.24元。2月3日盘中最低价报10.87元。尖峰集团当前最新总市值45.54亿元，在水泥板块市值排名14/21，在两市A股市值排名3734/5186。截至2026年1月31日，公司累计回购股份1,789,200股，占公司总股本的0.433%，已支付资金总额2,091.67万元，回购价格区间为11.07元/股至12.27元/股。上述回购进展符合相关规定及方案要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800001220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0235","BK0188","600668","BK0186"],"gpt_icon":0},{"id":"2608674318","title":"尖峰集团（600668）披露以集中竞价交易方式回购公司股份的进展公告，2月2日股价下跌1.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608674318","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608674318?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:27","pubTimestamp":1770042441,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘，尖峰集团报收于10.89元，较前一交易日下跌1.8%，最新总市值为44.96亿元。近日，尖峰集团发布《关于以集中竞价交易方式回购公司股份的进展公告》。公告显示，公司于2025年4月18日召开董事会，审议通过以集中竞价交易方式回购股份的方案，拟用于员工持股计划或股权激励，回购资金总额为2,000万元至4,000万元，回购期限为董事会审议通过之日起12个月内，回购价格上限调整为12.42元/股。上述回购进展符合相关规定及方案要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200039318.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0188","600668","BK0235"],"gpt_icon":0},{"id":"2608077564","title":"每周股票复盘：尖峰集团（600668）预计2025年净利4.6亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2608077564","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608077564?lang=zh_cn&edition=full","pubTime":"2026-02-01 02:44","pubTimestamp":1769885052,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，尖峰集团报收于11.09元，较上周的11.78元下跌5.86%。本周，尖峰集团1月26日盘中最高价报11.81元。本周关注点业绩披露要点：尖峰集团预计2025年归属净利润4.6亿元，扣非净利亏损2.15亿元公司公告汇总：联营企业股权出售带来非经常性收益，医药主业受集采影响承压业绩披露要点尖峰集团发布业绩预告，预计2025年全年归属净利润盈利约4.6亿元。尖峰集团发布业绩预告，预计2025年全年扣非后净利润亏损约2.15亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100000817.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0235","600668","BK0188","BK0186"],"gpt_icon":0},{"id":"2606738792","title":"尖峰集团（600668）披露2025年年度业绩预告，1月27日股价下跌1.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606738792","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606738792?lang=zh_cn&edition=full","pubTime":"2026-01-27 22:45","pubTimestamp":1769525115,"startTime":"0","endTime":"0","summary":"截至2026年1月27日收盘，尖峰集团报收于11.49元，较前一交易日下跌1.46%，最新总市值为47.44亿元。该股当日开盘11.65元，最高11.65元，最低11.32元，成交额达7683.95万元，换手率为1.63%。近日，尖峰集团发布2025年年度业绩预告。公告显示，公司预计2025年年度实现归属于上市公司股东的净利润46,000万元左右，同比增长325.97%；扣除非经常性损益的净利润为-21,500万元左右，同比减少322.53%。上述数据未经审计，最终以2025年年度报告为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700042209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0235","600668","BK0186","BK0188"],"gpt_icon":0},{"id":"2606207134","title":"尖峰集团(600668.SH)发预增，预计2025年年度归母净利润同比增加325.97%左右","url":"https://stock-news.laohu8.com/highlight/detail?id=2606207134","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606207134?lang=zh_cn&edition=full","pubTime":"2026-01-27 17:44","pubTimestamp":1769507079,"startTime":"0","endTime":"0","summary":"智通财经APP讯，尖峰集团(600668.SH)发布2025年年度业绩预告，预计2025年年度实现归属于上市公司股东的净利润46,000万元左右，与上年同期相比，将增加35,201.19万元左右，同比增加325.97%左右。2025年年度归属于上市公司股东的净利润大幅增加、扣除非经常性损益的净利润大幅减少的主要原因是报告期公司权益法核算的联营企业天士力生物医药产业集团有限公司(以下简称：天士力集团)出售了其所持的股权资产，使得其报告期的利润大幅增长，该部分出售资产所得的收益为非经常性收益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397997.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"尖峰集团(600668.SH)发预增，预计2025年年度归母净利润同比增加325.97%左右","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600668"],"gpt_icon":0},{"id":"2604923783","title":"每周股票复盘：尖峰集团（600668）子公司撤回药品注册申请因需完善资料","url":"https://stock-news.laohu8.com/highlight/detail?id=2604923783","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604923783?lang=zh_cn&edition=full","pubTime":"2026-01-18 03:18","pubTimestamp":1768677490,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，尖峰集团报收于11.27元，较上周的11.5元下跌2.0%。本周，尖峰集团1月12日盘中最高价报11.52元。本周关注点公司公告汇总：子公司撤回药品注册临床试验申请，因需进一步完善申报资料。公司公告汇总尖峰集团全资子公司浙江尖峰药业有限公司收到国家药品监督管理局签发的关于“C2235和C2235片”的《药品注册申请终止通知书》，系尖峰药业主动撤回申请，原因为需进一步完善申报资料，待完善研究后将择期重新提交临床试验申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800000821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0235","600668","BK0186","BK0188"],"gpt_icon":0},{"id":"2603608256","title":"尖峰集团最新公告：子公司尖峰药业主动撤回“C2235和C2235片”药品注册临床试验申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2603608256","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603608256?lang=zh_cn&edition=full","pubTime":"2026-01-15 17:23","pubTimestamp":1768469037,"startTime":"0","endTime":"0","summary":"尖峰集团(600668.SH)公告称，公司全资子公司尖峰药业收到国家药品监督管理局签发的关于“C2235和C2235片”《药品注册申请终止通知书》，系尖峰药业主动撤回申请，待完善相关研究后择期重新提交药品注册临床试验申请。本次撤回不会对公司当期业绩产生重大影响，但创新药研发存在高科技、高风险特点，研发风险不可避免，敬请投资者谨慎决策，注意防范投资风险。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500028288.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","600668","BK0235","BK0188"],"gpt_icon":0},{"id":"2594244211","title":"每周股票复盘：尖峰集团（600668）尖峰药业通过GMP检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2594244211","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594244211?lang=zh_cn&edition=full","pubTime":"2025-12-28 03:04","pubTimestamp":1766862252,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，尖峰集团报收于11.11元，较上周的11.15元下跌0.36%。尖峰药业已取得他氟前列素原料药上市批准及滴眼液药品注册证书，本次通过检查具备原料药供应能力，保障滴眼液生产，丰富公司产品线。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800000629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0235","600668","BK0188","BK0186"],"gpt_icon":0},{"id":"2593983499","title":"尖峰集团(600668.SH)子公司尖峰药业通过药品GMP符合性检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2593983499","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593983499?lang=zh_cn&edition=full","pubTime":"2025-12-23 18:14","pubTimestamp":1766484860,"startTime":"0","endTime":"0","summary":"智通财经APP讯，尖峰集团(600668.SH)发布公告，近日，公司全资子公司浙江尖峰药业有限公司(简称“尖峰药业”)从浙江省药品监督管理局网站获悉GMP符合性检查结果公告(浙2025第0254号)。本次尖峰药业的他氟前列素原料药生产线通过GMP符合性检查，具备了该药品的原料药供应能力，保障了他氟前列素滴眼液的生产，进一步丰富了公司产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385005.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600668","BK0186","BK0235","BK0188"],"gpt_icon":0},{"id":"2585030931","title":"每周股票复盘：尖峰集团（600668）取消监事会并修订多项内控制度","url":"https://stock-news.laohu8.com/highlight/detail?id=2585030931","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585030931?lang=zh_cn&edition=full","pubTime":"2025-11-23 03:12","pubTimestamp":1763838735,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，尖峰集团报收于11.24元，较上周的11.96元下跌6.02%。本周关注点公司公告汇总：尖峰集团取消监事会并修订《公司章程》。公司公告汇总：审议通过新增3项、修订23项内控制度。同日，公司召开2025年第二次临时股东大会，审议通过关于取消监事会并修订《公司章程》的议案，以及修订《股东会议事规则》《董事会议事规则》《独立董事制度》等多项内控制度。审计委员会将依据新修订制度行使监事会职权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","600668","BK0235","BK0188"],"gpt_icon":0},{"id":"2585149991","title":"尖峰集团（600668）披露取消监事会并修订《公司章程》议案获通过，11月21日股价下跌3.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585149991","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585149991?lang=zh_cn&edition=full","pubTime":"2025-11-21 22:32","pubTimestamp":1763735562,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，尖峰集团报收于11.24元，较前一交易日下跌3.44%，最新总市值为46.41亿元。根据近日发布的公告，浙江尖峰集团股份有限公司于2025年11月21日召开2025年第二次临时股东大会，审议通过了关于取消监事会并修订《公司章程》的议案，以及修订公司部分内控制度的多项议案，包括《股东会议事规则》《董事会议事规则》和《独立董事制度》。上述议案均已获得出席会议股东所持表决权的过半数或三分之二以上通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100040362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600668","BK0188","BK0186","BK0235"],"gpt_icon":0},{"id":"2583452047","title":"尖峰集团(600668.SH)：JFAN-1001甲磺酸盐胶囊获得药物临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2583452047","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583452047?lang=zh_cn&edition=full","pubTime":"2025-11-14 15:39","pubTimestamp":1763105980,"startTime":"0","endTime":"0","summary":"据悉，JFAN-1001 甲磺酸盐胶囊是尖峰亦恩开发的抗肿瘤新药，注册分类属于化学药品1类，适应症为 EGFR-T790M 继发突变阳性的局部晚期或转移性非鳞非小细胞肺癌。尖峰亦恩JFAN-1001甲磺酸盐胶囊联合酒石酸长春瑞滨软胶囊的临床试验申请于2025年09月08日获得受理。截至目前，除本次新获得批准的临床试验外，JFAN-1001胶囊正在国内进行Ⅱ期临床试验，并已获得美国食品药品监督管理局药物临床试验许可。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369264.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"尖峰集团(600668.SH)：JFAN-1001甲磺酸盐胶囊获得药物临床试验批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0235","600668","BK0186","BK0188"],"gpt_icon":0},{"id":"2582337024","title":"尖峰集团（600668）披露拟取消监事会并调整公司治理结构，11月12日股价下跌0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582337024","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582337024?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:55","pubTimestamp":1762959318,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，尖峰集团报收于12.07元，较前一交易日下跌0.33%，最新总市值为49.84亿元。该股当日开盘12.09元，最高12.12元，最低11.99元，成交额达6811.34万元，换手率为1.37%。近日，尖峰集团发布《2025年第二次临时股东大会会议资料》，公告显示，公司拟取消监事会，原监事会的职权将由董事会审计委员会承接。上述事项已提交定于2025年11月21日召开的第二次临时股东大会审议，需经特别决议通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200041820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0235","BK0188","600668","BK0186"],"gpt_icon":0},{"id":"2582986438","title":"每周股票复盘：尖峰集团（600668）回购耗资1031.03万元，占比0.211%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582986438","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582986438?lang=zh_cn&edition=full","pubTime":"2025-11-09 04:39","pubTimestamp":1762634349,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，尖峰集团报收于11.9元，较上周的11.96元下跌0.5%。本周，尖峰集团11月3日盘中最高价报11.93元。截至2025年10月31日，公司累计回购股份871,800股，占公司总股本412,900,594股的0.211%，已支付资金总额1,031.03万元，回购成交价在11.63元/股至12.27元/股之间。上述回购进展符合相关规定及方案要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","600668","BK0188","BK0235"],"gpt_icon":0},{"id":"2580214247","title":"尖峰集团（600668）披露以集中竞价交易方式回购公司股份的进展公告，11月03日股价下跌0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580214247","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580214247?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:53","pubTimestamp":1762181596,"startTime":"0","endTime":"0","summary":"截至2025年11月3日收盘，尖峰集团报收于11.93元，较前一交易日下跌0.25%，最新总市值为49.26亿元。近日，尖峰集团发布关于以集中竞价交易方式回购公司股份的进展公告。公告显示，浙江尖峰集团股份有限公司于2025年4月18日召开董事会，审议通过以集中竞价交易方式回购股份的方案，回购期限为董事会审议通过之日起12个月内，拟回购金额为2,000万元至4,000万元，用于员工持股计划或股权激励，回购价格不超过15.00元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300036448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600668","BK0188","BK0186","BK0235"],"gpt_icon":0},{"id":"2580810476","title":"每周股票复盘：尖峰集团（600668）Q3净利增39.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580810476","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580810476?lang=zh_cn&edition=full","pubTime":"2025-11-02 03:27","pubTimestamp":1762025231,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，尖峰集团报收于11.96元，较上周的11.88元上涨0.67%。本周，尖峰集团10月30日盘中最高价报12.42元。股本股东变化截至2025年9月30日，尖峰集团股东户数为3.84万户，较6月30日增加6336户，增幅19.77%。第三季度单季主营收入6.21亿元，同比下降6.33%；归母净利润3205.78万元，同比上升39.76%；扣非净利润2940.07万元，同比上升43.51%。尖峰集团将于2025年11月21日召开2025年第二次临时股东大会，审议上述议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200000591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0188","BK0235","600668"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774358676760,"stockEarnings":[{"period":"1week","weight":-0.1093},{"period":"1month","weight":-0.1444},{"period":"3month","weight":-0.1181},{"period":"6month","weight":-0.1473},{"period":"1year","weight":0.1209},{"period":"ytd","weight":-0.1345}],"compareEarnings":[{"period":"1week","weight":-0.0665},{"period":"1month","weight":-0.0658},{"period":"3month","weight":-0.0272},{"period":"6month","weight":-0.0105},{"period":"1year","weight":0.1333},{"period":"ytd","weight":-0.0392}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江尖峰集团股份有限公司","boardCode":"AI0030","boardName":"非金属矿物制品业","stockholders":"38392人(较上一季度增加19.77%)","perCapita":"10754股","listingDate":"1993-07-28","address":"浙江省金华市婺城区婺江东路88号","registeredCapital":"41290万元","survey":" 浙江尖峰集团股份有限公司的主营业务是以建材和医药为主，以健康品、商贸物流、电缆等业务为辅。公司的主要产品是水泥、药品。","listedPrice":1},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"尖峰集团(600668)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供尖峰集团(600668)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"尖峰集团,600668,尖峰集团股票,尖峰集团股票老虎,尖峰集团股票老虎国际,尖峰集团行情,尖峰集团股票行情,尖峰集团股价,尖峰集团股市,尖峰集团股票价格,尖峰集团股票交易,尖峰集团股票购买,尖峰集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"尖峰集团(600668)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供尖峰集团(600668)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}